1. Home
  2. TYRA vs PDS Comparison

TYRA vs PDS Comparison

Compare TYRA & PDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TYRA
  • PDS
  • Stock Information
  • Founded
  • TYRA 2018
  • PDS 1951
  • Country
  • TYRA United States
  • PDS Canada
  • Employees
  • TYRA N/A
  • PDS N/A
  • Industry
  • TYRA Biotechnology: Pharmaceutical Preparations
  • PDS
  • Sector
  • TYRA Health Care
  • PDS
  • Exchange
  • TYRA Nasdaq
  • PDS Nasdaq
  • Market Cap
  • TYRA 819.3M
  • PDS 883.5M
  • IPO Year
  • TYRA 2021
  • PDS N/A
  • Fundamental
  • Price
  • TYRA $15.91
  • PDS $65.29
  • Analyst Decision
  • TYRA Strong Buy
  • PDS Buy
  • Analyst Count
  • TYRA 6
  • PDS 1
  • Target Price
  • TYRA $30.50
  • PDS $95.00
  • AVG Volume (30 Days)
  • TYRA 261.4K
  • PDS 64.3K
  • Earning Date
  • TYRA 03-18-2025
  • PDS 02-12-2025
  • Dividend Yield
  • TYRA N/A
  • PDS N/A
  • EPS Growth
  • TYRA N/A
  • PDS 62.11
  • EPS
  • TYRA N/A
  • PDS 12.37
  • Revenue
  • TYRA N/A
  • PDS $1,436,787,445.00
  • Revenue This Year
  • TYRA N/A
  • PDS $2.38
  • Revenue Next Year
  • TYRA N/A
  • PDS $2.42
  • P/E Ratio
  • TYRA N/A
  • PDS $5.28
  • Revenue Growth
  • TYRA N/A
  • PDS N/A
  • 52 Week Low
  • TYRA $12.34
  • PDS $55.33
  • 52 Week High
  • TYRA $29.60
  • PDS $79.07
  • Technical
  • Relative Strength Index (RSI)
  • TYRA 52.83
  • PDS 59.83
  • Support Level
  • TYRA $15.75
  • PDS $64.69
  • Resistance Level
  • TYRA $17.27
  • PDS $67.35
  • Average True Range (ATR)
  • TYRA 0.91
  • PDS 2.02
  • MACD
  • TYRA 0.20
  • PDS 0.40
  • Stochastic Oscillator
  • TYRA 65.99
  • PDS 78.78

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology The Company's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNAPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. Its lead product candidate is TYRA 300, an FGFR3 selective inhibitor with an initial focus on patients with metastatic urothelial carcinoma of the bladder and urinary tract (mUC).

About PDS Precision Drilling Corporation

Precision Drilling Corpd is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.

Share on Social Networks: